Found: 45
Select item for more details and to access through your institution.
Targeting mTOR signaling for the treatment of intrahepatic cholangiocarcinoma with TSC1/ARID1A mutations: a case report with an unexpected response.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241271793
- By:
- Publication type:
- Article
The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas.
- Published in:
- Genes, Chromosomes & Cancer, 2008, v. 47, n. 4, p. 299, doi. 10.1002/gcc.20533
- By:
- Publication type:
- Article
Correction: DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Healthy adiposity and extended lifespan in obese mice fed a diet supplemented with a polyphenol-rich plant extract.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45600-6
- By:
- Publication type:
- Article
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1437961
- By:
- Publication type:
- Article
IRF8-dependent molecular complexes control the Th9 transcriptional program.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01070-w
- By:
- Publication type:
- Article
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7592, doi. 10.3390/ijms24087592
- By:
- Publication type:
- Article
Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3343, doi. 10.3390/ijms23063343
- By:
- Publication type:
- Article
HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 3, p. 1167, doi. 10.3892/ijo.2014.2528
- By:
- Publication type:
- Article
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07224-8
- By:
- Publication type:
- Article
Somatic substitution signature as an innovative tool in lung cancer diagnosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51155-3
- By:
- Publication type:
- Article
Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1187052
- By:
- Publication type:
- Article
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0055103
- By:
- Publication type:
- Article
A Short Caspase-3 Isoform Inhibits Chemotherapy-Induced Apoptosis by Blocking Apoptosome Assembly.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0029058
- By:
- Publication type:
- Article
Custom multi-tumor next-generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three-year clinical use.
- Published in:
- International Journal of Molecular Medicine, 2022, v. 49, n. 5, p. N.PAG, doi. 10.3892/ijmm.2022.5113
- By:
- Publication type:
- Article
Corrigendum: The receptor NLRP3 is a transcriptional regulator of T<sub>H</sub>2 differentiation.
- Published in:
- Nature Immunology, 2015, v. 16, n. 12, p. 1292, doi. 10.1038/ni1215-1292a
- By:
- Publication type:
- Article
The receptor NLRP3 is a transcriptional regulator of T<sub>H</sub>2 differentiation.
- Published in:
- Nature Immunology, 2015, v. 16, n. 8, p. 859, doi. 10.1038/ni.3202
- By:
- Publication type:
- Article
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of T<sub>H</sub>9 cells.
- Published in:
- Nature Immunology, 2014, v. 15, n. 8, p. 758, doi. 10.1038/ni.2925
- By:
- Publication type:
- Article
Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.
- Published in:
- International Journal of Nanomedicine, 2017, v. 12, p. 6357, doi. 10.2147/IJN.S139167
- By:
- Publication type:
- Article
OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01829-4
- By:
- Publication type:
- Article
Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors.
- Published in:
- EMBO Reports, 2024, v. 25, n. 3, p. 1469, doi. 10.1038/s44319-024-00089-7
- By:
- Publication type:
- Article
Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18786, doi. 10.1002/cam4.6498
- By:
- Publication type:
- Article
Impact of proton therapy on antitumor immune response.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92942-1
- By:
- Publication type:
- Article
PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31593-w
- By:
- Publication type:
- Article
Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.863057
- By:
- Publication type:
- Article
HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2009, doi. 10.3390/cancers16112009
- By:
- Publication type:
- Article
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3129, doi. 10.3390/cancers15123129
- By:
- Publication type:
- Article
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1299, doi. 10.3390/cancers15041299
- By:
- Publication type:
- Article
Alternative Splicing in Cancer and Immune Cells.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1726, doi. 10.3390/cancers14071726
- By:
- Publication type:
- Article
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4394, doi. 10.3390/cancers13174394
- By:
- Publication type:
- Article
An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3113, doi. 10.3390/cancers13133113
- By:
- Publication type:
- Article
Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1198-9
- By:
- Publication type:
- Article
Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 169, doi. 10.1186/s12885-015-1198-9
- By:
- Publication type:
- Article
Transcriptional regulation of the survivin gene.
- Published in:
- Molecular Biology Reports, 2014, v. 41, n. 1, p. 233, doi. 10.1007/s11033-013-2856-0
- By:
- Publication type:
- Article
ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 200, doi. 10.1002/ijc.33539
- By:
- Publication type:
- Article
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00395-0
- By:
- Publication type:
- Article
Long-term response to Olaparib in carcinomatous meningitis of a BRCA2 mutated ovarian cancer: A case report.
- Published in:
- Molecular & Clinical Oncology, 2020, v. 13, n. 1, p. 73, doi. 10.3892/mco.2020.2035
- By:
- Publication type:
- Article
Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
- Published in:
- Histopathology, 2021, v. 79, n. 5, p. 810, doi. 10.1111/his.14429
- By:
- Publication type:
- Article
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
- Published in:
- Frontiers in Pharmacology, 2015, p. 1, doi. 10.3389/fphar.2015.00147
- By:
- Publication type:
- Article
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 11, p. 3112, doi. 10.1002/ijc.32620
- By:
- Publication type:
- Article
PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
- Published in:
- 2016
- By:
- Publication type:
- journal article